Serum Biomarker Panels for the Diagnosis of Gastric Cancer

Overview

Journal Cancer Med

Specialty Oncology

Date 2019 Mar 16

PMID 30873760

Citations 75

Authors

Dan Wu

Pinglu Zhang

Ji Ma

Jinbo Xu

Li Yang

Weidan Xu

Haifeng Que

Meifen Chen

Hongtao Xu

Affiliations

Soon will be listed here.

Abstract

Gastric cancer is a leading cause of mortality due to neoplastic disease. Although early detection of gastric cancers can decrease the mortality rate, it remains a diagnostic challenge because of the lack of effective biomarkers. In this study, fifteen gastric cancer patients and ten healthy subjects were recruited to assess novel serum biomarkers for gastric cancer using antibody microarray technology. ELISA was utilized to validate the antibody array results. As a result, compared to the controls, eleven cytokines were found to be significantly increased in gastric cancer, including interferon gamma receptor 1 (IFNGR1), neurogenic locus notch homolog protein 3 (Notch-3), tumor necrosis factor receptor superfamily member 19L (TNFRSF19L), growth hormone receptor (GHR), signaling lymphocytic activation molecule family 8 (SLAMF8), folate receptor beta (FR-beta), integrin alpha 5, galectin-8, erythropoietin-producing hepatocellular A1 (EphA1), epiregulin, and fibroblast growth factor 12 (FGF-12) with P < 0.05. ELISA validation supported the results of the antibody array. More importantly, most of these eleven cytokines, including IFNGR1, TNFRSF19L, GHR, SLAMF8, FR-beta, and integrin alpha 5 were discovered to be elevated in gastric cancer serum samples for the first time in this study, suggesting that these proteins may serve as novel biomarkers for the early diagnosis and prognosis determination of gastric cancer.

Citing Articles

mA transferase KIAA1429 mediates the upregulation of LncRNA LINC00968 promoting the progression of gastric cancer cells.

Liu H, Yang M, Zhang C, Zhang Y, Wang Y, Chen Y Hereditas. 2025; 162(1):34.

PMID: 40069867 PMC: 11895323. DOI: 10.1186/s41065-025-00393-9.

Relationship Between MIC-1, VEGF, and TGF-β1 and Clinicopathologic Stage and Lymph Node Metastasis in Gastric Cancer.

Sheng J, Wang J, Ma T, He P Int J Gen Med. 2025; 18:955-965.

PMID: 40007699 PMC: 11853773. DOI: 10.2147/IJGM.S497572.

Dysregulated transfer RNA-derived small RNAs as potential gastric cancer biomarkers.

Yuan J, Gu W, Xu T, Zhang Y, Shen L, Yan J Exp Biol Med (Maywood). 2024; 249:10170.

PMID: 39735780 PMC: 11673218. DOI: 10.3389/ebm.2024.10170.

ADAMTS12 serves as a novel prognostic biomarker and promotes proliferation and invasion in gastric cancer.

Gao R, Hu Y, Yuan Q Discov Oncol. 2024; 15(1):837.

PMID: 39720953 PMC: 11669643. DOI: 10.1007/s12672-024-01724-4.

Identification and validation of serum MUC17 as a non-invasive early warning biomarker for screening of gastric intraepithelial neoplasia.

Yang B, Xie X, Jin X, Huang X, He Y, Yin K Transl Oncol. 2024; 51:102207.

PMID: 39580962 PMC: 11625214. DOI: 10.1016/j.tranon.2024.102207.

References

Canedo P, Corso G, Pereira F, Lunet N, Suriano G, Figueiredo C . The interferon gamma receptor 1 (IFNGR1) -56C/T gene polymorphism is associated with increased risk of early gastric carcinoma. Gut. 2008; 57(11):1504-8. DOI: 10.1136/gut.2007.143578. View

Nakayama F, Muller K, Hagiwara A, Ridi R, Akashi M, Meineke V . Involvement of intracellular expression of FGF12 in radiation-induced apoptosis in mast cells. J Radiat Res. 2008; 49(5):491-501. DOI: 10.1269/jrr.08021. View

Sanchez-Carbayo M, Socci N, Lozano J, Haab B, Cordon-Cardo C . Profiling bladder cancer using targeted antibody arrays. Am J Pathol. 2006; 168(1):93-103. PMC: 1592677. DOI: 10.2353/ajpath.2006.050601. View

Li Y, Yang Y, Lu M, Shen L . Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer. Hepatogastroenterology. 2011; 58(112):2166-70. DOI: 10.5754/hge11753. View

Johansson J, Tabor V, Wikell A, Jalkanen S, Fuxe J . TGF-β1-Induced Epithelial-Mesenchymal Transition Promotes Monocyte/Macrophage Properties in Breast Cancer Cells. Front Oncol. 2015; 5:3. PMC: 4306317. DOI: 10.3389/fonc.2015.00003. View

Hunt R, Camilleri M, Crowe S, El-Omar E, Fox J, Kuipers E . The stomach in health and disease. Gut. 2015; 64(10):1650-68. PMC: 4835810. DOI: 10.1136/gutjnl-2014-307595. View

Lin Y, Huang R, Chen L, Li S, Shi Q, Jordan C . Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int J Cancer. 2004; 109(4):507-15. DOI: 10.1002/ijc.11724. View

Weitman S, Lark R, Coney L, Fort D, Frasca V, Zurawski Jr V . Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 1992; 52(12):3396-401. View

Parker N, Turk M, Westrick E, Lewis J, Low P, Leamon C . Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem. 2005; 338(2):284-93. DOI: 10.1016/j.ab.2004.12.026. View

10.

Romero X, Sintes J, Engel P . Role of SLAM family receptors and specific adapter SAP in innate-like lymphocytes. Crit Rev Immunol. 2014; 34(4):263-99. DOI: 10.1615/critrevimmunol.2014010538. View

11.

Hadari Y, Levy Y, Amsterdam A, Alon R, Zakut R, Zick Y . Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci. 2000; 113 ( Pt 13):2385-97. DOI: 10.1242/jcs.113.13.2385. View

12.

Chhabra Y, Waters M, Brooks A . Role of the growth hormone-IGF-1 axis in cancer. Expert Rev Endocrinol Metab. 2019; 6(1):71-84. DOI: 10.1586/eem.10.73. View

13.

Saito T, Kimura M, Kawasaki T, Sato S, Tomita Y . Correlation between integrin alpha 5 expression and the malignant phenotype of transitional cell carcinoma. Br J Cancer. 1996; 73(3):327-31. PMC: 2074419. DOI: 10.1038/bjc.1996.57. View

14.

Crane L, Arts H, van Oosten M, Low P, van der Zee A, van Dam G . The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer. Cell Oncol (Dordr). 2011; 35(1):9-18. PMC: 3268989. DOI: 10.1007/s13402-011-0052-6. View

15.

Troncoso M, Ferragut F, Bacigalupo M, Cardenas Delgado V, Nugnes L, Gentilini L . Galectin-8: a matricellular lectin with key roles in angiogenesis. Glycobiology. 2014; 24(10):907-14. DOI: 10.1093/glycob/cwu054. View

16.

De Calisto J, Wang N, Wang G, Yigit B, Engel P, Terhorst C . SAP-Dependent and -Independent Regulation of Innate T Cell Development Involving SLAMF Receptors. Front Immunol. 2014; 5:186. PMC: 4005954. DOI: 10.3389/fimmu.2014.00186. View

17.

Wu S, Liu H, Zhang H, Lin C, Li R, Cao Y . Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery. Tumour Biol. 2016; 37(9):12635-12642. DOI: 10.1007/s13277-016-5175-y. View

18.

Gonzalez C, Agudo A . Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go. Int J Cancer. 2011; 130(4):745-53. DOI: 10.1002/ijc.26430. View

19.

Wu W, Tse T, Sung J, Li Z, Yu L, Cho C . Expression of ErbB receptors and their cognate ligands in gastric and colon cancer cell lines. Anticancer Res. 2009; 29(1):229-34. View

20.

Nakagawa M, Inokuchi M, Takagi Y, Kato K, Sugita H, Otsuki S . Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric Cancer. Ann Surg Oncol. 2014; 22(7):2329-35. DOI: 10.1245/s10434-014-4231-3. View